CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 77 filers reported holding CYTOSORBENTS CORP in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $56,000 | -37.1% | 17,653 | -17.2% | 0.00% | – |
| Q4 2021 | $89,000 | -53.6% | 21,321 | -9.8% | 0.00% | – |
| Q3 2021 | $192,000 | -55.2% | 23,625 | -58.5% | 0.00% | -100.0% |
| Q2 2021 | $429,000 | -20.6% | 56,880 | -8.5% | 0.00% | 0.0% |
| Q1 2021 | $540,000 | +9.1% | 62,166 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $495,000 | -0.2% | 62,166 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $496,000 | -3.7% | 62,166 | +19.6% | 0.00% | 0.0% |
| Q2 2020 | $515,000 | +41.1% | 51,994 | +10.0% | 0.00% | 0.0% |
| Q1 2020 | $365,000 | +102.8% | 47,278 | +1.2% | 0.00% | – |
| Q4 2019 | $180,000 | -23.4% | 46,733 | 0.0% | 0.00% | – |
| Q3 2019 | $235,000 | -23.9% | 46,733 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $309,000 | -12.7% | 46,733 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $354,000 | -3.3% | 46,733 | +3.3% | 0.00% | 0.0% |
| Q4 2018 | $366,000 | -37.3% | 45,251 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $584,000 | +18.0% | 45,251 | +4.1% | 0.00% | 0.0% |
| Q2 2018 | $495,000 | – | 43,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
| Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
| Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
| EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
| EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
| Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
| Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
| Avenir Corp | 76,390 | $617,000 | 0.08% |
| Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
| Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |